205
Views
2
CrossRef citations to date
0
Altmetric
Review

Improving Outcomes for Patients with Age-Related Macular Degeneration and Cataracts: The Importance of Including an Assessment of Activities of Daily Life (ADL)

ORCID Icon, , , &
Pages 3333-3339 | Published online: 10 Aug 2021

References

  • Wong L, Su X, Li X, Cheung C, Cheng CY, Wong T. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2:e106–e116. doi:10.1016/S2214-109X(13)70145-1
  • Prenner J, Halperin L, Rycroft C, Hogue S, Williams Liu Z, Seibert R. Disease burden in the treatment of age-related macular degeneration: findings from a time-and-motion study. Am J Ophthalmol. 2015;160:725–731. doi:10.1016/j.ajo.2015.06.023
  • The Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122:564–572. doi:10.1001/archopht.122.4.564
  • Grzybowski A, Wasinska-Borowiec W, ALio J, Amat-Peral P, Tabanero J. Intraocular lenses in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2017;255:1687–1696. doi:10.1007/s00417-017-3740-8
  • AAO PPP Retina/Vitreous Committee. Age-related macular degeneration PPP 2019; 2019. Available from: https://www.aao.org/preferred-practice-pattern/age-related-macular-degeneration-ppp. Accessed March 24, 2020.
  • Fleckenstein M, Mitchell P, Bailey Freund K, et al. The progression of geographic atrophy secondary to age-related macular degeneration. Ophthalmology. 2018;125:369–390. doi:10.1016/j.ophtha.2017.08.038
  • Gahn G, Khanani A. New therapies of neovascular AMD beyond anti-VEGF injections. Vision. 2018;2:15. doi:10.3390/vision2010015
  • Mitchell P, Liew G, Gopinath B, Wong T. Age-related macular degeneration. Lancet. 2018;392:1147–1159. doi:10.1016/S0140-6736(18)31550-2
  • Linblad A, Clemens T. Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report No. 14. Arch Ophthalmol. 2005;123:1207–1214.
  • Sivaprasad S, Tschosik E, Kapre A, et al. Reliability and construct validity of the NEI VFQ-25 in a subset of patients with geographic atrophy from the phase 2 Mahalo study. Am J Ophthalmol. 2018;190:1–8. doi:10.1016/j.ajo.2018.03.006
  • Kimel M, Leidy N, Tschosik E, et al. Functional Reading Independence (FRI) index: a new patient-reported outcome measure for patients with geographic atrophy. IOVS. 2017;57:6298–6304.
  • Varma R, Souied E, Tufail A, et al. Maximum reading speed in patients with geographic atrophy secondary to age-related macular degeneration. IOVS. 2018;59:AMD195–AMD201.
  • Gopinath B, Liew G, Burlutsky G, Mitchell P. Age-related macular degeneration and 5-year incidence of impaired activities of daily living. Maturitas. 2014;77:263–266. doi:10.1016/j.maturitas.2013.12.001
  • Higgins B, Taylor D, Crabb D. Assessing everyday visual function in dry AMD - what matters to the person? Eye News. 2019;25. Available from: https://www.eyenews.uk.com/features/ophthalmology/post/assessing-everyday-visual-function-in-dry-amd-what-matters-to-the-person.
  • Dunbar H, Dhawahir-Scala F. A discussion of commercially available itra-ocular telescopic implants for patients with age-related macular degeneration. Ophthalmol Ther. 2018;7:33–48. doi:10.1007/s40123-018-0129-7
  • Agarwal A, Lipshitz I, Jacob S, et al. Mirror telescopic intraocular lens for age-related macular degeneration - Design and preliminary clinical results of the Lipshitz macular implant. J Cataract Refract Surg. 2008;34:87–94. doi:10.1016/j.jcrs.2007.08.031
  • Orzalesi N, Pierrottet C, Zenoni S, Savaresi C. The IOL-Vip System: a double intraocular lens implant for visual rehabilitation of patients with macular disease. Ophthalmol. 2007;114:860–865. doi:10.1016/j.ophtha.2007.01.005
  • Qureshi M, Robbie S, Hengerer F, Auffarth G, Conrad-Hengerer I, Artal P. Consecutive case series of 244 age-related macular degeneration patients undergoing implantation with an extended macular vision IOL. Eur J Ophthalmol. 2018;28:198–203. doi:10.5301/ejo.5001052
  • Hengerer F, Auffarth G, Robbie S, Yildirim T, Conrad-Hengerer I. First results of a new hyperaspheric add-on intraocular lens approach implanted in pseudophakic patients with age-related macular degeneration. Ophthalmol Retina. 2018;2:900–905. doi:10.1016/j.oret.2018.02.003
  • Robbie S, Tabanero J, Artal P, Qureshi M. Initial clinical results with a novel monofocal-type intraocular lens for extended macular vision in patients with macular degeneration. J Refract Surg. 2018;34:718–725. doi:10.3928/1081597X-20180831-01
  • Borkenstein A, Borkenstein EM. A case report detailing use of a new intraocular lens with advanced technology, designed specifically for patients with center-involving macular disorders. Medicine. 2019;98:e16583. doi:10.1097/MD.0000000000016583
  • Nekolova J, Rozsival P, Sin M, Jiraskova N. Scharioth Macula Lens: a new intraocular implant for low-vision patients with stabilized maculopathy - first experience. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017;161:206–209. doi:10.5507/bp.2017.014
  • Bereczki Á. Experiences with the Scharioth Macula Lens - new hope for patients with dry macula degeneration. Rom J Ophthalmol. 2019;63:128–134. doi:10.22336/rjo.2019.19
  • Srinivasan S, Scharioth G, Riehl A, et al. Implantation of Scharioth macula lens in patients with age-related macular degenration: results of a propsective European multicentre clinical trial. BMJ Open Ophthalmol. 2019;4:e000322. doi:10.1136/bmjophth-2019-000322
  • Potgeiter F, Claoue C. Safety and efficacy of an intraocular Fresnel prism intraocular lens in patients with advanced macular disease: initial clinical experience. J Cataract Refract Surg. 2014;40:1085–1091. doi:10.1016/j.jcrs.2013.10.049
  • Borkenstein A, Borkenstein EM. Cataract surgery with implantation of a high-add intraocular lens LENTIS® MAX LS-313 MF80 in end-stage, age-related macular degeneration: a case report of magnifying surgery. Clin Case Rep. 2018;7:74–78. doi:10.1002/ccr3.1912
  • Boyer D, Bailey Freund K, Regillo C, Levy M, Garg S. Long-term (60-month) results for the implantable miniature telescope: efficacy and safety outcomes stratified by age in patients with end-stage age-related macular degeneration. Clin Ophthalmol. 2015;9:1099–1107. doi:10.2147/OPTH.S86208
  • Hau V, London N, Dalton M. The treatment paradigm for the implantable miniature telescope. Ophthalmol Ther. 2016;5:21–30. doi:10.1007/s40123-016-0047-5
  • US Food & Drug Administration; July 07, 2010. Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P050034 . Accessed April 01, 2020.
  • National Institute for Health and Care Excellence; September 28, 2016. Available from: https://www.nice.org.uk/guidance/ipg565/resources/miniature-lens-system-implantation-for-advanced-agerelated-macular-degeneration-pdf-1899872049404869https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P050034 . Accessed March 25, 2020.
  • Finger R, Schmitz-Valckenberg S, Schmid M, et al. MACUSTAR: development and clinical validation of functional, structural, and patient-reported endpoints in intermediate age-related macular degeneration. Opthalmol. 2019;241:61–72. doi:10.1159/000491402
  • ALio J, Mulet E, Ruiz-Moreno J, Jose Sanchez M, Galal A. Intraocular telescopic lens evaluation in patients with age-related macular degeneration. J Cataract Refract Surg. 2004;30:1177–1189. doi:10.1016/j.jcrs.2003.10.038
  • Hengerer F, Artal P, Kohnen T, Conrad-Hengerer I. Initial clinical results of a new telescopic IOL implanted in patients with dry age-related macular degeneration. J Refract Surg. 2015;31:158–162. doi:10.3928/1081597X-20150220-03
  • Tabanero J, Qureshi M, Robbie S, Artal P. An aspheric intraocular telescope for age-related macular degeneration patients. Biomed Optics. 2015;6:1010–1020. doi:10.1364/BOE.6.001010
  • Qureshi M, Robbie S, Tabanero J. Injectable intraocular telescope: pilot study. J Cataract Refract Surg. 2015;41:2125–2135. doi:10.1016/j.jcrs.2015.03.021